WO2022116378A1 - Method for cleaving dna using soybean extract bowman-birk inhibitor - Google Patents

Method for cleaving dna using soybean extract bowman-birk inhibitor Download PDF

Info

Publication number
WO2022116378A1
WO2022116378A1 PCT/CN2021/073010 CN2021073010W WO2022116378A1 WO 2022116378 A1 WO2022116378 A1 WO 2022116378A1 CN 2021073010 W CN2021073010 W CN 2021073010W WO 2022116378 A1 WO2022116378 A1 WO 2022116378A1
Authority
WO
WIPO (PCT)
Prior art keywords
dna
bbi
cleavage
solution
bowman
Prior art date
Application number
PCT/CN2021/073010
Other languages
French (fr)
Chinese (zh)
Inventor
杨兆琪
龚森怡
尚孟迪
金坚
Original Assignee
江南大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江南大学 filed Critical 江南大学
Publication of WO2022116378A1 publication Critical patent/WO2022116378A1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/30Nucleotides
    • C12P19/34Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Definitions

  • Nucleic acid is an important biological macromolecule and an indispensable component of all known life forms. It plays a very important role in biological growth, development and reproduction. Nucleic acid cleaving agents play a vital role in the field of nucleic acid chemistry research. In the field of biochemistry and molecular biology, the research on nucleic acid cleaving agents has received extensive attention. Through the research on nucleic acid cleaving agents, some important information in organisms can be obtained. , provides the mechanism of action of nucleases in vivo, and has great research value in medicine and biology.
  • the invention provides a DNA cutting method, which is characterized in that the DNA is cut by using soybean Bowman-Birk trypsin inhibitor.
  • the reaction temperature is 35-40°C.
  • the buffer is BR buffer.
  • Example 1 Effect of ionic species on DNA cleavage by BBI-A
  • pUC19 DNA 250ng, final concentration of protein solution: 5mg/mL, 37°C, reaction for 2h.
  • lane 1 DNA control (plasmid pUC19 DNA before treatment);
  • lane 2-6 Cu 2+ concentrations were 0.1 mmol/L, 0.5 mmol/L, 1 mmol/L, 5 mmol/L, and 10 mmol/L, respectively.
  • Photograph and data analysis by using a gel imager to photograph the agarose gel and save the original file, use software to analyze the original file, as can be seen from Figure 2, Cu 2+ of different concentrations (from 0.1mmol /L ⁇ 10mmol/L) had little effect on the results of assisted BBI-A cleavage of DNA.
  • Example 3 Effects of BBI-A concentration changes on DNA cleavage under ion-free conditions
  • lane 1 DNA control
  • Electrophoresis Close the lid of the electrophoresis apparatus in the correct direction, turn on the switch, turn on the power, adjust the voltage to 100V, the current to 260mA, and run the gel for 40min to allow the cut DNA and its fragments to migrate in the agarose gel.
  • lane 1 DNA control (plasmid pUC19 DNA before treatment); lane 2-6: 0.5h, 1h, 1.5h, 2h, 2.5h.
  • Electrophoresis Close the lid of the electrophoresis apparatus in the correct direction, turn on the switch, turn on the power, adjust the voltage to 100V, the current to 260mA, and run the gel for 40min to allow the cut DNA and its fragments to migrate in the agarose gel.
  • No. 1 is the DNA control
  • experimental group 1 is a group that did not add DNA T4 ligase for normal reaction
  • experimental group 2 is a group that added DNA T4 ligase to react for 2 hours after purification, as shown in the experimental results
  • lane 2 is the experimental result of purification and re-ligation after cleavage. From the situation of the bands in lane 2, it can be seen that there is no band with a slower mobility than the cleavage band, which proves that no ligation product DNA is regenerated, which indicates that the added T4 DNA ligase No effect, the cut DNA is not ligated again.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Disclosed is a method for cleaving DNA using a soybean extract Bowman-Birk inhibitor, which belongs to the technical field of medicines. Provided is a new use of a soybean Bowman-Birk trypsin inhibitor BBI-A. The BBI-A is used to cleave DNA, and the cleavage efficiency can reach 100% due to the optimization of conditions, such that DNA can be effectively cleaved. A new possibility is provided for preparing a DNA structural probe and potentially preparing an anti-tumor drug.

Description

大豆提取物Bowman-Birk inhibitor切割DNA的方法Method for cutting DNA by Bowman-Birk inhibitor of soybean extract 技术领域technical field
本发明涉及大豆提取物Bowman-Birk inhibitor切割DNA的方法,属于医药技术领域。The invention relates to a method for cutting DNA by Bowman-Birk inhibitor of soybean extract, and belongs to the technical field of medicine.
背景技术Background technique
核酸是重要的生物大分子,是所有已知生命形式必不可少的组成物质,它在生物的生长、发育和繁殖等活动中,具有非常重要的作用。在核酸化学研究领域核酸切割剂具有至关重要的作用,在生物化学和分子生物学领域,核酸切割剂的研究受到人们广泛的关注,通过对核酸切割剂的研究可以获得生物体内的一些重要信息,提供生物体内核酸酶的作用机制,在医药及生物方向具有极大的研究价值。Nucleic acid is an important biological macromolecule and an indispensable component of all known life forms. It plays a very important role in biological growth, development and reproduction. Nucleic acid cleaving agents play a vital role in the field of nucleic acid chemistry research. In the field of biochemistry and molecular biology, the research on nucleic acid cleaving agents has received extensive attention. Through the research on nucleic acid cleaving agents, some important information in organisms can be obtained. , provides the mechanism of action of nucleases in vivo, and has great research value in medicine and biology.
Bowman–Birk inhibitor(BBI)是从大豆中分离出的一种典型的天然蛋白酶抑制剂,迄今为止,已从大豆中分离出五种BBI亚型(A、B、C-II、D-II和E-I),据现有研究已知,在植物中的作用中BBI-A蛋白酶抑制剂与在人体中的作用α-1抗胰蛋白酶很相似,两者都因为这样的特点具有较高的抗癌活性,在对各自机体防护中起着至关重要的作用。正因BBI-A蛋白酶抑制剂有着这样与生命息息相关的活性,因此现在越来越多人们关注研究BBI-A。Bowman–Birk inhibitor (BBI) is a typical natural protease inhibitor isolated from soybean. So far, five BBI subtypes (A, B, C-II, D-II and E-I), according to existing research, BBI-A protease inhibitor in plant is very similar to α-1 antitrypsin in human, both of them have higher anti-cancer effect because of this feature Activity, plays a vital role in the protection of their respective bodies. Because BBI-A protease inhibitors have such activities that are closely related to life, more and more people are paying attention to the study of BBI-A.
据现有实验结果可知,国内外对BBI-A的研究主要集中在BBI-A本身的提取、分离、结构、生物活性和应用前景等,尤其是对抗炎、抗病毒领域研究较多,而在其他领域涉及较少。According to the existing experimental results, the research on BBI-A at home and abroad mainly focuses on the extraction, separation, structure, biological activity and application prospects of BBI-A itself, especially in the fields of anti-inflammatory and anti-virus. Less involved in other areas.
因此,进一步挖掘BBI-A的潜在功能,将能够更加有助于更好地利用BBI-A。Therefore, further excavating the potential functions of BBI-A will be able to help make better use of BBI-A.
发明内容SUMMARY OF THE INVENTION
针对现有技术存在的上述问题,本发明申请人提供了一种BBI-A来切割DNA,本发明的目的是提供一种BBI-A在质粒DNA切割方面的应用,实现了一种新的DNA切割方式。本发明BBI-A对DNA存在切割作用且确定BBI-A切割DNA的最佳条件。In view of the above problems existing in the prior art, the applicant of the present invention provides a BBI-A to cut DNA, the purpose of the present invention is to provide a kind of application of BBI-A in the cutting of plasmid DNA, and realize a new DNA cutting method. The BBI-A of the present invention has a cleavage effect on DNA and the optimal conditions for the cleavage of DNA by BBI-A are determined.
本发明提供了一种DNA的切割方法,其特征在于,利用大豆Bowman-Birk胰蛋白酶抑制剂切割DNA。The invention provides a DNA cutting method, which is characterized in that the DNA is cut by using soybean Bowman-Birk trypsin inhibitor.
在本发明的一种实施方式中,所述大豆Bowman-Birk胰蛋白酶抑制剂(BBI-A)的氨基酸序列如SEQ ID NO.1所示。In one embodiment of the present invention, the amino acid sequence of the soybean Bowman-Birk trypsin inhibitor (BBI-A) is shown in SEQ ID NO.1.
在本发明的一种实施方式中,在反应体系中加入1-15mg/mL的BBI-A。In one embodiment of the present invention, 1-15 mg/mL of BBI-A is added to the reaction system.
在本发明的一种实施方式中,反应体系中含有金属离子。In one embodiment of the present invention, the reaction system contains metal ions.
在本发明的一种实施方式中,所述金属离子的浓度为0.1-10mmol/L。In an embodiment of the present invention, the concentration of the metal ions is 0.1-10 mmol/L.
在本发明的一种实施方式中,所述金属离子包括Mg 2+、Cu 2+、Zn 2+和/或Ca 2+In one embodiment of the present invention, the metal ions include Mg 2+ , Cu 2+ , Zn 2+ and/or Ca 2+ .
在本发明的一种实施方式中,反应时间不低于0.5h。In one embodiment of the present invention, the reaction time is not less than 0.5h.
在本发明的一种实施方式中,反应温度为35-40℃。In one embodiment of the present invention, the reaction temperature is 35-40°C.
本发明提供了一种DNA切割试剂盒,其特征在于,所述试剂盒包括缓冲液、大豆Bowman-Birk胰蛋白酶抑制剂和金属离子。The present invention provides a DNA cleavage kit, which is characterized in that the kit comprises buffer, soybean Bowman-Birk trypsin inhibitor and metal ions.
在本发明的一种实施方式中,所述金属离子包括Mg 2+、Cu 2+、Zn 2+和/或Ca 2+In one embodiment of the present invention, the metal ions include Mg 2+ , Cu 2+ , Zn 2+ and/or Ca 2+ .
在本发明的一种实施方式中,所述缓冲液为BR缓冲液。In one embodiment of the present invention, the buffer is BR buffer.
在本发明的一种实施方式中,所述BR缓冲液的浓度为120mmol/L、pH为7.0。In an embodiment of the present invention, the concentration of the BR buffer is 120 mmol/L and the pH is 7.0.
本发明提供了所述BBI-A,或所述方法,或所述试剂盒在切割DNA中的应用。The present invention provides the application of the BBI-A, or the method, or the kit in cutting DNA.
在本发明的一种实施方式中,所述DNA包括环状DNA、链状DNA。In one embodiment of the present invention, the DNA includes circular DNA, strand DNA.
本发明有益的技术效果在于:The beneficial technical effects of the present invention are:
1.本发明以BBI-A与质粒pUC19 DNA为主要材料,将其混合反应,并通过使用DNA琼脂糖凝胶电泳技术检测BBI-A对DNA反应结果,探究BBI-A与DNA的相互作用。同时更改反应物浓度、反应时间等,通过凝胶电泳法测定反应结果,确定BBI-A与DNA相互作用的最佳条件,使得切割率可达到100%。1. The present invention uses BBI-A and plasmid pUC19 DNA as the main materials, mixes them for reaction, and detects the reaction result of BBI-A on DNA by using DNA agarose gel electrophoresis technology to explore the interaction between BBI-A and DNA. At the same time, the concentration of the reactants, the reaction time, etc. were changed, and the reaction results were determined by gel electrophoresis to determine the optimal conditions for the interaction between BBI-A and DNA, so that the cleavage rate could reach 100%.
2.本发明的BBI-A具有核酸酶活性,能够在一定程度上切割DNA,对探索BBI-A与DNA的作用以及设计新的DNA结构探针等方面具有一定的指导意义,并使其在药物研发领域作为新的抗肿瘤药物成为可能。2. The BBI-A of the present invention has nuclease activity, can cut DNA to a certain extent, and has certain guiding significance for exploring the role of BBI-A and DNA and designing new DNA structure probes, etc. The field of drug development is possible as new antitumor drugs.
附图说明Description of drawings
图1为BBI-A切割DNA的最佳辅助金属离子结果示意图;(A)中的泳道1:DNA对照组;泳道2:Mg 2+,0.1mM;泳道3:Zn 2+,0.1mM;泳道4:Cu 2+,0.1mM;泳道5:Ca 2+,0.1mM;泳道6:添加蛋白、不含离子;(B)为不同离子条件下的切割结果。 Figure 1 is a schematic diagram of the best auxiliary metal ion results for DNA cleavage by BBI-A; (A) Lane 1: DNA control group; Lane 2: Mg 2+ , 0.1mM; Lane 3: Zn 2+ , 0.1mM; Lane 4: Cu 2+ , 0.1 mM; Lane 5: Ca 2+ , 0.1 mM; Lane 6: added protein without ions; (B) is the cleavage results under different ion conditions.
图2为BBI-A切割DNA的最佳辅助金属离子浓度示意图;(A)中的泳道1:DNA对照组;泳道2-6中的Cu 2+终浓度分别为:0.1mM,0.5mM,1mM,5mM,10mM;(B)为各Cu 2+浓度条件下的切割结果。 Figure 2 is a schematic diagram of the optimal concentration of auxiliary metal ions for DNA cleavage by BBI-A; lane 1 in (A): DNA control group; the final concentrations of Cu 2+ in lanes 2-6 are: 0.1 mM, 0.5 mM, 1 mM, respectively , 5mM, 10mM; (B) is the cleavage result under the condition of each Cu 2+ concentration.
图3为BBI-A切割DNA的最佳蛋白浓度的结果示意图;(A)中的泳道1-5分别为1mg/L,3mg/L,5mg/L,10mg/L,15mg/L的BBI-A;(B)为不同BBI-A浓度条件下的切割结果。Figure 3 is a schematic diagram of the results of the optimal protein concentration of BBI-A cutting DNA; (A) lanes 1-5 are 1mg/L, 3mg/L, 5mg/L, 10mg/L, 15mg/L BBI- A; (B) are the cleavage results under different BBI-A concentrations.
图4为BBI-A切割DNA的最佳反应时间的结果示意图;(A)中的泳道1为DNA对照组;泳道2-6中的反应时间分别为:0.5h,1h,1.5h,2h,2.5h;(B)分别是不同反应时间下的切割结果。Figure 4 is a schematic diagram of the results of the optimal reaction time for BBI-A to cut DNA; (A) lane 1 is the DNA control group; the reaction times in lanes 2-6 are: 0.5h, 1h, 1.5h, 2h, 2.5h; (B) are the cleavage results under different reaction times.
图5为混合体系BBI-A切割图;泳道1-2分别为DNA对照组、BBI-A切割组、4;泳道3:BBI-A切割组,加入DMSO;泳道4:BBI-A切割组,加入正丁醇;泳道5:BBI-A切割组,加入KI;泳道6:BBI-A切割组,加入NaN 3Figure 5 is the BBI-A cleavage diagram of the mixed system; lanes 1-2 are the DNA control group, the BBI-A cleavage group, and the 4; n-Butanol was added; lane 5: BBI-A cleavage group, KI was added; lane 6: BBI-A cleavage group, NaN 3 was added.
图6为切割后DNA的连接图;泳道1-3分别为对DNA对照组、BBI-A切割组、连接组。Figure 6 is the connection diagram of DNA after cutting; lanes 1-3 are the DNA control group, the BBI-A cutting group, and the connecting group, respectively.
具体实施方式Detailed ways
下述实施例中所使用的BBI-A为大豆Bowman-Birk胰蛋白酶抑制剂,其氨基酸序列如SEQ ID NO.1所示。BBI-A used in the following examples is soybean Bowman-Birk trypsin inhibitor, and its amino acid sequence is shown in SEQ ID NO.1.
实施例1:离子种类对BBI-A切割DNA的影响Example 1: Effect of ionic species on DNA cleavage by BBI-A
利用不同的离子种类及浓度进行实验,可以找到切割DNA效果最好的最佳离子种类Experiments with different ion species and concentrations can find the best ion species with the best cleavage effect on DNA
(1)配制样品:向1.5mL的EP管中加入,依次加入10.5μL的BR缓冲液(120mmol/L,pH7.0),5μL的蛋白溶液(20mg/ml),2μL的1mmol/L的金属离子溶液,我们选择Mg 2+,Zn 2+,Cu 2+和Ca 2+这四种离子进行实验。通过涡旋混匀仪使其充分混合均匀,离心后加入2.5μL的100ng/μL的pUC19 DNA质粒,反应体系共20μL,做好编号标记后经混合均匀再用离心机离心,密封置于37℃恒温金属浴反应2h。 (1) Prepare the sample: add it to a 1.5 mL EP tube, and then add 10.5 μL of BR buffer (120 mmol/L, pH 7.0), 5 μL of protein solution (20 mg/ml), and 2 μL of 1 mmol/L metal For the ionic solution, we choose four ions of Mg 2+ , Zn 2+ , Cu 2+ and Ca 2+ for experiments. Mix thoroughly with a vortex mixer. After centrifugation, add 2.5 μL of 100 ng/μL pUC19 DNA plasmid. The reaction system is 20 μL in total. After labeling, mix well and centrifuge in a centrifuge. Seal and store at 37°C. Constant temperature metal bath reaction 2h.
(2)1%琼脂糖凝胶的制备:称取1g的琼脂糖固体加入到已装有100mL的1×TAE溶液的250mL的锥形瓶中,用微波炉反复加热再摇匀使固体完全溶解,直至溶液呈澄清透明状。将琼脂糖溶液置于室温下逐渐冷却至60℃以下时,加入7μL的EB溶液(溴化乙锭),震荡锥形瓶使得溶液混合均匀,再将琼脂糖溶液缓慢倒入已准备好的水平胶框中,插入梳子。让凝胶自然晾干成形,将挡板和梳子拔掉。(2) Preparation of 1% agarose gel: Weigh 1 g of solid agarose and add it to a 250 mL conical flask containing 100 mL of 1×TAE solution. Repeat heating with a microwave oven and then shake to dissolve the solid completely. until the solution is clear and transparent. When the agarose solution is placed at room temperature and gradually cooled to below 60°C, add 7 μL of EB solution (ethidium bromide), shake the conical flask to make the solution evenly mixed, and then slowly pour the agarose solution into the prepared level. In the plastic box, insert the comb. Allow the gel to dry naturally and remove the baffle and comb.
(3)加样:从恒温器中取出完全反应的样品,用移液枪吸取4μL的6×Loading Buffer缓冲液加入离心管中,用旋涡混匀仪充分振荡混合均匀后再进行离心。溶液混合均匀后,吸取样品加入到点样孔槽。(3) Sample loading: Take out the fully reacted sample from the thermostat, pipet 4 μL of 6×Loading Buffer into the centrifuge tube, and use a vortex mixer to fully shake and mix evenly before centrifuging. After the solution is evenly mixed, draw the sample and add it to the spotting well.
pUC19 DNA:250ng,蛋白溶液终浓度:5mg/mL,37℃,2h。图1中,泳道1:DNA control(处理前质粒pUC19 DNA);泳道2-5:分别是终浓度均为0.1mmol/L的Mg 2+,Zn 2+,Cu 2+,Ca 2+;泳道6:不含金属离子。 pUC19 DNA: 250ng, final concentration of protein solution: 5mg/mL, 37°C, 2h. In Figure 1, lane 1: DNA control (plasmid pUC19 DNA before treatment); lanes 2-5: Mg 2+ , Zn 2+ , Cu 2+ , Ca 2+ with a final concentration of 0.1 mmol/L respectively; lanes 6: Does not contain metal ions.
(4)电泳:将电泳仪盖子按正确方向合紧,打开开关通电,调节电压至100V,电流为 260mA,跑胶时间40min,让被切割的pUC19质粒DNA及其碎片在琼脂糖凝胶中迁移。(4) Electrophoresis: Tighten the lid of the electrophoresis apparatus in the correct direction, turn on the switch, turn on the power, adjust the voltage to 100V, the current to 260mA, and run the gel for 40min, so that the cleaved pUC19 plasmid DNA and its fragments migrate in the agarose gel .
(5)拍照及数据分析:通过使用凝胶成像仪对琼脂糖凝胶拍照并保存原文件,用软件对原文件进行分析,由图1可知,在pH7.0的BR缓冲液体系中,在离子浓度1mmol/L条件下,四种离子对辅助BBI-A切割DNA的效果影响差别不大,基本都可以达到43%,其中Cu 2+辅助BBI-A切割pUC19 DNA质粒的效果较好于其他三种离子,达到52.8%的切割率。因此,选择四种金属离子中效果较好的Cu 2+作为实验辅助离子来进行实验。 (5) Photographing and data analysis: The agarose gel was photographed by using a gel imager and the original file was saved, and the original file was analyzed by software. Under the condition of ion concentration of 1 mmol/L, the effect of the four ions on the effect of assisted BBI-A on DNA cleavage is not much different, and they can basically reach 43%. Among them, the effect of Cu 2+ assisted BBI-A on the cleavage of pUC19 DNA plasmid is better than that of other ions. With three ions, a cutting rate of 52.8% was achieved. Therefore, Cu 2+ , which has a better effect among the four metal ions, was selected as the experimental auxiliary ion for the experiment.
实施例2:离子浓度对BBI-A切割DNA的影响Example 2: Effect of ion concentration on DNA cleavage by BBI-A
使用凝胶电泳法检测离子浓度对BBI-A切割DNA的影响。选择Cu 2+作为反应的辅助离子,并利用不同的离子浓度(0.1mmol/L、0.5mmol/L、1mmol/L、5mmol/L、10mmol/L)来进行实验。 The effect of ion concentration on DNA cleavage by BBI-A was examined using gel electrophoresis. Cu 2+ was chosen as the auxiliary ion for the reaction, and experiments were carried out with different ion concentrations (0.1 mmol/L, 0.5 mmol/L, 1 mmol/L, 5 mmol/L, 10 mmol/L).
(1)配制样品:向1.5mL的EP管中加入,依次加入10.5μL的BR缓冲液(120mmol/L,pH7.0),5μL的目标化合物溶液(20mg/ml),2μL的不同浓度的硫酸铜溶液(1mmol/L、5mmol/L、10mmol/L、50mmol/L、100mmol/L)。通过涡旋混匀仪使其充分混合均匀,离心后加入2.5μL的100ng/μL的pUC19 DNA质粒,做好编号标记后经混合均匀再用离心机离心,密封置于37℃恒温金属浴反应2h。(1) Prepare the sample: add it to a 1.5mL EP tube, and sequentially add 10.5μL of BR buffer (120mmol/L, pH7.0), 5μL of target compound solution (20mg/ml), and 2μL of sulfuric acid of different concentrations Copper solution (1mmol/L, 5mmol/L, 10mmol/L, 50mmol/L, 100mmol/L). Mix thoroughly with a vortex mixer, add 2.5 μL of 100 ng/μL pUC19 DNA plasmid after centrifugation, label the number, mix well, then centrifuge with a centrifuge, seal and place in a constant temperature metal bath at 37°C for 2 hours of reaction .
(2)1%琼脂糖凝胶的制备:称取1g的琼脂糖固体加入到已装有100mL的1×TAE溶液的250mL的锥形瓶中,用微波炉反复加热再摇匀使固体完全溶解,直至溶液呈澄清透明状。将溶液置于室温下逐渐冷却至60℃以下时,加入7μL的EB溶液(溴化乙锭),震荡锥形瓶使得溶液混合均匀,再将琼脂糖溶液缓慢倒入已准备好的水平胶框中,插入梳子。让凝胶自然晾干成形,将挡板和梳子拔掉。(2) Preparation of 1% agarose gel: Weigh 1 g of solid agarose and add it to a 250 mL conical flask containing 100 mL of 1×TAE solution. Repeat heating with a microwave oven and then shake to dissolve the solid completely. until the solution is clear and transparent. When the solution was gradually cooled to below 60°C at room temperature, 7 μL of EB solution (ethidium bromide) was added, the conical flask was shaken to make the solution evenly mixed, and then the agarose solution was slowly poured into the prepared horizontal plastic frame. , insert the comb. Allow the gel to dry naturally and remove the baffle and comb.
(3)加样:从恒温器中取出完全反应的样品,用移液枪吸取4μL的6×Loading Buffer缓冲液加入离心管中,用旋涡混匀仪充分振荡混合均匀后再进行离心。溶液混合均匀后,吸取20μL的样品垂直小心加入到点样孔槽。(3) Sample loading: Take out the fully reacted sample from the thermostat, pipet 4 μL of 6×Loading Buffer into the centrifuge tube, and use a vortex mixer to fully shake and mix evenly before centrifuging. After the solution is evenly mixed, pipette 20 μL of the sample vertically and carefully into the spotting well slot.
pUC19 DNA:250ng,蛋白溶液终浓度:5mg/mL,37℃,反应2h。图2中,泳道1:DNA control(处理前质粒pUC19 DNA);泳道2-6:Cu 2+浓度分别为0.1mmol/L,0.5mmol/L,1mmol/L,5mmol/L,10mmol/L。 pUC19 DNA: 250ng, final concentration of protein solution: 5mg/mL, 37°C, reaction for 2h. In Figure 2, lane 1: DNA control (plasmid pUC19 DNA before treatment); lane 2-6: Cu 2+ concentrations were 0.1 mmol/L, 0.5 mmol/L, 1 mmol/L, 5 mmol/L, and 10 mmol/L, respectively.
(4)电泳:将电泳仪盖子按正确方向合紧,打开开关通电,调节电压至100V,电流为260mA,跑胶时间40min,让被切割的DNA及其碎片在琼脂糖凝胶中迁移。(4) Electrophoresis: Close the lid of the electrophoresis apparatus in the correct direction, turn on the switch, turn on the power, adjust the voltage to 100V, the current to 260mA, and run the gel for 40min to allow the cut DNA and its fragments to migrate in the agarose gel.
(5)拍照及数据分析:通过使用凝胶成像仪对琼脂糖凝胶拍照并保存原文件,用软件对原文件进行分析,由图2可以看出,不同浓度的Cu 2+(由0.1mmol/L~10mmol/L)对辅助BBI- A切割DNA的结果影响区别不大。 (5) Photograph and data analysis: by using a gel imager to photograph the agarose gel and save the original file, use software to analyze the original file, as can be seen from Figure 2, Cu 2+ of different concentrations (from 0.1mmol /L~10mmol/L) had little effect on the results of assisted BBI-A cleavage of DNA.
实施例3:无离子条件下BBI-A浓度变化对切割DNA的影响Example 3: Effects of BBI-A concentration changes on DNA cleavage under ion-free conditions
由于离子对于DNA的切割效率并未有很大的提升,因此,选择在无离子条件下对反应体系进一步优化。Since the cleavage efficiency of DNA was not greatly improved by ions, the reaction system was further optimized under ion-free conditions.
(1)配制样品:向1.5mL的EP管中加入,将20mg/ml的蛋白质溶液依次加入1μL、3μL、5μL、10μL、15μL,然后用BR缓冲液(120mmol/L,pH7.0)补足到17.5μL。通过涡旋混匀仪使其充分混合均匀,离心后加入2.5μL的100ng/μL的pUC19 DNA质粒,做好编号标记后经混合均匀再用离心机离心,密封置于37℃恒温金属浴反应2h。(1) Prepare the sample: add it to a 1.5 mL EP tube, add 20 mg/ml protein solution to 1 μL, 3 μL, 5 μL, 10 μL, and 15 μL in turn, and then add BR buffer (120 mmol/L, pH 7.0) to make up 17.5 μL. Mix thoroughly with a vortex mixer, add 2.5 μL of 100 ng/μL pUC19 DNA plasmid after centrifugation, make a serial number mark, mix well, then centrifuge with a centrifuge, seal it and place it in a constant temperature metal bath at 37°C for 2 hours .
(2)1%琼脂糖凝胶的制备:称取1g的琼脂糖固体加入到已装有100mL的1×TAE溶液的250mL的锥形瓶中,用微波炉反复加热再摇匀使固体完全溶解,直至溶液呈澄清透明状。将溶液置于室温下逐渐冷却至60℃以下时,加入7μL的EB溶液(溴化乙锭),震荡锥形瓶使得溶液混合均匀,再将琼脂糖溶液缓慢倒入已准备好的水平胶框中,插入梳子。让凝胶自然晾干成形,将挡板和梳子拔掉。(2) Preparation of 1% agarose gel: Weigh 1 g of solid agarose and add it to a 250 mL conical flask containing 100 mL of 1×TAE solution. Repeat heating with a microwave oven and then shake to dissolve the solid completely. until the solution is clear and transparent. When the solution was gradually cooled to below 60°C at room temperature, 7 μL of EB solution (ethidium bromide) was added, the conical flask was shaken to make the solution evenly mixed, and then the agarose solution was slowly poured into the prepared horizontal plastic frame. , insert the comb. Allow the gel to dry naturally and remove the baffle and comb.
(3)加样:从恒温器中取出完全反应的样品,用移液枪吸取4μL的6×Loading Buffer缓冲液加入离心管中,用旋涡混匀仪充分振荡混合均匀后再进行离心。溶液混合均匀后,吸取20μL的样品垂直小心加入到点样孔槽。(3) Sample loading: Take out the fully reacted sample from the thermostat, pipet 4 μL of 6×Loading Buffer into the centrifuge tube, and use a vortex mixer to fully shake and mix evenly before centrifuging. After the solution is evenly mixed, pipette 20 μL of the sample vertically and carefully into the spotting well slot.
pUC19 250ng,37℃,2h。图3中,泳道1:DNA control;泳道2-6:BBI-A溶液终浓度分别为1mmol/L,3mmol/L,5mmol/L,10mmol/L,15mmol/L。pUC19 250ng, 37℃, 2h. In Figure 3, lane 1: DNA control; lane 2-6: BBI-A solution final concentrations are 1mmol/L, 3mmol/L, 5mmol/L, 10mmol/L, 15mmol/L, respectively.
(4)电泳:将电泳仪盖子按正确方向合紧,打开开关通电,调节电压至100V,电流为260mA,跑胶时间40min,让被切割的DNA及其碎片在琼脂糖凝胶中迁移。(4) Electrophoresis: Close the lid of the electrophoresis apparatus in the correct direction, turn on the switch, turn on the power, adjust the voltage to 100V, the current to 260mA, and run the gel for 40min to allow the cut DNA and its fragments to migrate in the agarose gel.
(5)拍照及数据分析:通过使用凝胶成像仪对琼脂糖凝胶拍照并保存原文件,用软件对原文件进行分析,如图3可知,在无离子的条件下,随着浓度的增加,切割效果也明显越来越好,在蛋白浓度达到15mmol/L时,切割率可达到100%。(5) Photographing and data analysis: The agarose gel is photographed by using a gel imager and the original file is saved, and the original file is analyzed by software, as shown in Figure 3, under the condition of no ions, with the increase of the concentration , the cutting effect is obviously getting better and better, when the protein concentration reaches 15mmol/L, the cutting rate can reach 100%.
实施例4:反应时间对BBI-A切割DNA的影响Example 4: Effect of reaction time on DNA cleavage by BBI-A
探究反应时间对BBI-A切割DNA的影响。The effect of reaction time on DNA cleavage by BBI-A was investigated.
(1)配制样品:向1.5mL的EP管中加入,依次加入10.5μL的BR缓冲液(120mmol/L,pH7.0),5μL的蛋白(20mg/mL)溶液,2μL的1mmol/L的硫酸铜溶液。通过涡旋混匀仪使其充分混合均匀,离心后加入2.5μL的100ng/μL的pUC19DNA质粒,终浓度为5mg/mL的蛋白,做好编号标记后经混合均匀再用离心机离心,密封置于37℃恒温金属浴分别反应0.5~2.5h。(1) Prepare the sample: add it to a 1.5mL EP tube, and then add 10.5μL of BR buffer (120mmol/L, pH7.0), 5μL of protein (20mg/mL) solution, and 2μL of 1mmol/L sulfuric acid copper solution. Mix thoroughly with a vortex mixer. After centrifugation, add 2.5 μL of 100 ng/μL pUC19 DNA plasmid with a final concentration of 5 mg/mL of protein. After labeling, mix well and then centrifuge in a centrifuge. Seal it. React in a constant temperature metal bath at 37°C for 0.5-2.5h respectively.
(2)1%琼脂糖凝胶的制备:称取1g的琼脂糖固体加入到已装有100mL的1×TAE溶液的250mL的锥形瓶中,用微波炉反复加热再摇匀使固体完全溶解,直至溶液呈澄清透明状。将溶液置于室温下逐渐冷却至60℃以下时,加入7μL的EB溶液(溴化乙锭),震荡锥形瓶使得溶液混合均匀,再将琼脂糖溶液缓慢倒入已准备好的水平胶框中,插入梳子。让凝胶自然晾干成形,将挡板和梳子拔掉。(2) Preparation of 1% agarose gel: Weigh 1 g of solid agarose and add it to a 250 mL conical flask containing 100 mL of 1×TAE solution. Repeat heating with a microwave oven and then shake to dissolve the solid completely. until the solution is clear and transparent. When the solution was gradually cooled to below 60°C at room temperature, 7 μL of EB solution (ethidium bromide) was added, the conical flask was shaken to make the solution evenly mixed, and then the agarose solution was slowly poured into the prepared horizontal plastic frame. , insert the comb. Allow the gel to dry naturally and remove the baffle and comb.
(3)加样:从恒温器中取出完全反应的样品,用移液枪吸取4μL的6×Loading Buffer缓冲液加入离心管中,用旋涡混匀仪充分振荡混合均匀后再进行离心。溶液混合均匀后,吸取20μL的样品垂直小心加入到点样孔槽。(3) Sample loading: Take out the fully reacted sample from the thermostat, pipet 4 μL of 6×Loading Buffer into the centrifuge tube, and use a vortex mixer to fully shake and mix evenly before centrifuging. After the solution is evenly mixed, pipette 20 μL of the sample vertically and carefully into the spotting well slot.
图4中,泳道1:DNA control(处理前质粒pUC19 DNA);泳道2-6:0.5h,1h,1.5h,2h,2.5h。In Figure 4, lane 1: DNA control (plasmid pUC19 DNA before treatment); lane 2-6: 0.5h, 1h, 1.5h, 2h, 2.5h.
(4)电泳:将电泳仪盖子按正确方向合紧,打开开关通电,调节电压至100V,电流为260mA,跑胶时间40min,让被切割的DNA及其碎片在琼脂糖凝胶中迁移。(4) Electrophoresis: Close the lid of the electrophoresis apparatus in the correct direction, turn on the switch, turn on the power, adjust the voltage to 100V, the current to 260mA, and run the gel for 40min to allow the cut DNA and its fragments to migrate in the agarose gel.
(5)拍照及数据分析:通过使用凝胶成像仪对琼脂糖凝胶拍照并保存原文件,用软件对原文件进行分析。如上图4可以看出,随着反应时间的延长,BBI-A对DNA的切割效果越来越明显。且从图中我们可以看到control组DNA几乎没有发生断裂,而添加了BBI-A的样品即便仅仅反应2h,其对DNA的切割率也已经达到了52.4%,可见BBI-A对DNA具有较好的切割作用。(5) Photographing and data analysis: The agarose gel is photographed by using a gel imager and the original file is saved, and the original file is analyzed by software. As can be seen from Figure 4 above, with the prolongation of the reaction time, the cleavage effect of BBI-A on DNA became more and more obvious. And from the figure, we can see that the DNA of the control group is almost not broken, and the sample added with BBI-A has a cleavage rate of 52.4% even if it is only reacted for 2 hours. Good cutting action.
实施例5:DNA切割机理验证Example 5: DNA cleavage mechanism verification
(1)切割实验(1) Cutting experiment
在反应体系中添加自由基清除剂观察切割结果的变化来判断BBI-A切割DNA的机理。其中含BR缓冲液(120mmol/L,pH7.0),DNA浓度为100ng/μL,蛋白溶液浓度为20mg/ml,DMSO、正丁醇、KI和NaN 3溶液浓度为1M。按照下表将试剂依次添加完毕后,震荡离心后置于恒温水浴箱于37℃恒温反应2h。 A free radical scavenger was added to the reaction system to observe the changes of the cleavage results to judge the mechanism of DNA cleavage by BBI-A. It contains BR buffer (120 mmol/L, pH 7.0), the concentration of DNA is 100 ng/μL, the concentration of protein solution is 20 mg/ml, and the concentration of DMSO, n-butanol, KI and NaN 3 solution is 1 M. After adding the reagents in sequence according to the following table, shake and centrifuge them and place them in a constant temperature water bath for 2 hours at a constant temperature of 37°C.
表1切割机理探讨的反应体系Table 1. Reaction systems discussed in cleavage mechanism
Figure PCTCN2021073010-appb-000001
Figure PCTCN2021073010-appb-000001
Figure PCTCN2021073010-appb-000002
Figure PCTCN2021073010-appb-000002
如图5可知,在羟基自由基淬灭剂如DMSO及叔丁醇的存在下,BBI-A切割DNA并没有被抑制,说明BBI-A混合物中没有羟基自由基,不属于自由基切割机理。而在单线态氧淬灭剂叠氮化钠和超氧化物淬灭剂碘化钾的存在下,BBI-A对DNA的切割明显收到了抑制。因此我们可以初步判定BBI-A切割DNA的切割机理有可能是水解裂解或是氧化裂解,具体情况可以结合DNA重新连接试验结果观察。As shown in Figure 5, in the presence of hydroxyl radical quenchers such as DMSO and tert-butanol, the cleavage of DNA by BBI-A was not inhibited, indicating that there were no hydroxyl radicals in the BBI-A mixture, which did not belong to the mechanism of radical cleavage. In the presence of the singlet oxygen quencher sodium azide and the superoxide quencher potassium iodide, the cleavage of DNA by BBI-A was significantly inhibited. Therefore, we can preliminarily determine that the cleavage mechanism of BBI-A cutting DNA may be hydrolytic cleavage or oxidative cleavage.
(2)连接实验(2) Connection experiment
对照组含250ng DNA;切割组含2.5μL的DNA(100ng/μL),BBI-A溶液10μL(20mg/mL),7.5μL的BR缓冲液(120mmol/L,pH7.0);连接组为切割组经纯化后,浓缩样品体积到15μL并加到离心管中,再加入2μL的连接酶缓冲液,0.5μL T4DNA连接酶,再补充2.5μL去离子水形成总体积为20μL的样品进行重新连接实验。The control group contained 250 ng DNA; the cutting group contained 2.5 μL DNA (100 ng/μL), 10 μL BBI-A solution (20 mg/mL), and 7.5 μL BR buffer (120 mmol/L, pH 7.0); the ligation group was cutting After the group was purified, the sample volume was concentrated to 15 μL and added to a centrifuge tube, then 2 μL of ligase buffer, 0.5 μL of T4 DNA ligase, and 2.5 μL of deionized water were added to form a total volume of 20 μL of sample for re-ligation experiments. .
表2连接反应体系Table 2 ligation reaction system
Figure PCTCN2021073010-appb-000003
Figure PCTCN2021073010-appb-000003
如图6所示,1号为DNA对照,实验组1为没有添加DNA T4连接酶正常反应的一组,实验组2则为纯化后添加了DNA T4连接酶反应2h的一组,如实验结果可知,泳道2是切割后纯化再连接的实验结果,从泳道2条带情况可知没有比切割条带迁移率更慢的条带出现,证明没有再产生连接产物DNA,这说明添加的T4DNA连接酶没有产生作用,被切割的DNA没有被再次连接起来。已知水解切割只是破坏磷酸二酯键,并不会造成DNA彻底的损坏,且被切割后的DNA可由T4DNA连接酶重新连接起来。由此可知,BBI-A切割DNA是由单线态氧和超氧化物引起的,属于氧化裂解。As shown in Figure 6, No. 1 is the DNA control, experimental group 1 is a group that did not add DNA T4 ligase for normal reaction, and experimental group 2 is a group that added DNA T4 ligase to react for 2 hours after purification, as shown in the experimental results It can be seen that lane 2 is the experimental result of purification and re-ligation after cleavage. From the situation of the bands in lane 2, it can be seen that there is no band with a slower mobility than the cleavage band, which proves that no ligation product DNA is regenerated, which indicates that the added T4 DNA ligase No effect, the cut DNA is not ligated again. It is known that hydrolytic cleavage only destroys phosphodiester bonds, and does not cause complete damage to DNA, and the cleaved DNA can be reconnected by T4 DNA ligase. It can be seen that the DNA cleavage by BBI-A is caused by singlet oxygen and superoxide, which belongs to oxidative cleavage.
实施例6:DNA切割试剂盒的制备Example 6: Preparation of DNA cleavage kit
试剂盒中包含BR缓冲液(120mmol/L,pH 7.0)、BBI-A、及金属离子,金属离子包括Mg 2+,Cu 2+、Zn 2+或Ca 2+;在使用时,BBI-A的终浓度加至1-15mg/mL,金属离子浓度优选为0.1~10mM。 The kit contains BR buffer (120mmol/L, pH 7.0), BBI-A, and metal ions, including Mg 2+ , Cu 2+ , Zn 2+ or Ca 2+ ; when used, BBI-A The final concentration of metal ions is added to 1-15 mg/mL, and the metal ion concentration is preferably 0.1-10 mM.
虽然本发明已以较佳实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人, 在不脱离本发明的精神和范围内,都可做各种的改动与修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed above with preferred embodiments, it is not intended to limit the present invention. Anyone who is familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, The protection scope of the present invention should be defined by the claims.

Claims (12)

  1. 一种切割DNA的方法,其特征在于,利用大豆Bowman-Birk胰蛋白酶抑制剂切割DNA。A method for cleaving DNA, characterized in that the DNA is cleaved with soybean Bowman-Birk trypsin inhibitor.
  2. 根据权利要求1所述的方法,其特征在于,所述大豆Bowman-Birk胰蛋白酶抑制剂的氨基酸序列如SEQ ID NO.1所示。The method according to claim 1, wherein the amino acid sequence of the soybean Bowman-Birk trypsin inhibitor is shown in SEQ ID NO.1.
  3. 根据权利要求2所述的方法,其特征在于,反应体系中大豆Bowman-Birk胰蛋白酶抑制剂的浓度为1-15mg/mL。The method according to claim 2, wherein the concentration of soybean Bowman-Birk trypsin inhibitor in the reaction system is 1-15 mg/mL.
  4. 根据权利要求3所述的方法,其特征在于,反应体系中含有金属离子。The method according to claim 3, wherein the reaction system contains metal ions.
  5. 根据权利要求4所述的方法,其特征在于,所述金属离子的浓度为0.1-10mmol/L。The method according to claim 4, wherein the concentration of the metal ions is 0.1-10 mmol/L.
  6. 根据权利要求5所述的方法,其特征在于,所述金属离子包括Mg 2+、Cu 2+、Zn 2+和/或Ca 2+The method of claim 5, wherein the metal ions include Mg 2+ , Cu 2+ , Zn 2+ and/or Ca 2+ .
  7. 根据权利要求6所述的方法,其特征在于,反应时间不低于0.5h。The method according to claim 6, wherein the reaction time is not less than 0.5h.
  8. 一种DNA切割试剂盒,其特征在于,所述试剂盒包括缓冲液、大豆Bowman-Birk胰蛋白酶抑制剂和金属离子。A DNA cleavage kit, characterized in that the kit comprises buffer, soybean Bowman-Birk trypsin inhibitor and metal ions.
  9. 根据权利要求8所述的试剂盒,其特征在于,所述金属离子包括Mg 2+、Cu 2+、Zn 2+和/或Ca 2+The kit according to claim 8, wherein the metal ions comprise Mg 2+ , Cu 2+ , Zn 2+ and/or Ca 2+ .
  10. 根据权利要求9所述的试剂盒,其特征在于,所述缓冲液为BR缓冲液。The kit according to claim 9, wherein the buffer is a BR buffer.
  11. 大豆Bowman-Birk胰蛋白酶抑制剂,或权利要求1-7任一所述方法,或权利要求8-10任一所述试剂盒在切割DNA中的应用。Soybean Bowman-Birk trypsin inhibitor, or the method of any one of claims 1-7, or the application of any one of the kits of claims 8-10 in cutting DNA.
  12. 根据权利要求11所述的应用,其特征在于,所述DNA包括环状DNA、链状DNA。The application according to claim 11, wherein the DNA comprises circular DNA and strand DNA.
PCT/CN2021/073010 2020-12-02 2021-01-21 Method for cleaving dna using soybean extract bowman-birk inhibitor WO2022116378A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202011401295.5 2020-12-02
CN202011401295.5A CN112553274B (en) 2020-12-02 2020-12-02 Method for cutting DNA by soybean extract Bowman-Birk inhibitor

Publications (1)

Publication Number Publication Date
WO2022116378A1 true WO2022116378A1 (en) 2022-06-09

Family

ID=75048314

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2021/073010 WO2022116378A1 (en) 2020-12-02 2021-01-21 Method for cleaving dna using soybean extract bowman-birk inhibitor

Country Status (2)

Country Link
CN (1) CN112553274B (en)
WO (1) WO2022116378A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513307A (en) * 2014-12-09 2015-04-15 江南大学 Method for recovery of Kunitz and Bowman-Birk trypsin inhibitors from soybean whey
CN105462987A (en) * 2016-01-29 2016-04-06 中国科学院华南植物园 New application of OsBBTI4 (oryza sativa Bowman-Birk trypsin inhibitor 4) gene
CN110483634A (en) * 2019-08-27 2019-11-22 合肥天汇孵化科技有限公司 A kind of purification process of soybean trypsin inhibitor crude extract

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916627B2 (en) * 2002-11-27 2005-07-12 St. Jude Children's Research Hospital ATM kinase compositions and methods
EP2292641B1 (en) * 2003-11-06 2017-12-06 Danisco US Inc. Expression in filamentous fungi of protease inhibitors and variants thereof
TWI412367B (en) * 2006-12-28 2013-10-21 Medarex Llc Chemical linkers and cleavable substrates and conjugates thereof
BRPI0823193A2 (en) * 2008-10-15 2019-09-24 Danisco Us Inc modified variant bowman birk protease inhibitors
WO2013152291A1 (en) * 2012-04-05 2013-10-10 University Of Southern California Cell therapy technology to deliver radio-protective peptides
CN105567766A (en) * 2016-01-28 2016-05-11 扬州大学 Method for cleaving DNA with thermostable recombinant HNH type endonuclease
CN108330151B (en) * 2018-02-09 2020-06-23 如东百奥百乐生物科技有限公司 Deoxyribozyme cleavage method
CN111467493A (en) * 2019-01-23 2020-07-31 首都师范大学 Human REV 3L protein cleavage inhibitor and application thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104513307A (en) * 2014-12-09 2015-04-15 江南大学 Method for recovery of Kunitz and Bowman-Birk trypsin inhibitors from soybean whey
CN105462987A (en) * 2016-01-29 2016-04-06 中国科学院华南植物园 New application of OsBBTI4 (oryza sativa Bowman-Birk trypsin inhibitor 4) gene
CN110483634A (en) * 2019-08-27 2019-11-22 合肥天汇孵化科技有限公司 A kind of purification process of soybean trypsin inhibitor crude extract

Also Published As

Publication number Publication date
CN112553274A (en) 2021-03-26
CN112553274B (en) 2023-06-13

Similar Documents

Publication Publication Date Title
Siegel et al. Removal of the Alu structural domain from signal recognition particle leaves its protein translocation activity intact
US4908318A (en) Nucleic acid extraction methods
CA2354379C (en) Method for isolating dna from biological materials
CA3049139A1 (en) Compositions, methods, and kits for isolating nucleic acids
AU2014405969A1 (en) Method for constructing nucleic acid single-stranded cyclic library and reagents thereof
DE59610721D1 (en) METHOD AND DEVICE FOR SIMULTANEOUS ISOLATION OF GENOMIC DNA AND HIGH-PURITY TOTAL RNS
CA2310782A1 (en) Methods of nucleic acid isolation
CA2694411A1 (en) An improved nucleic acid purification method
US20220073965A1 (en) Method for quickly extracting long-fragment genomic dna by single reaction tube, and kit
JPH09327291A (en) Extraction and purification of rna
JP4241183B2 (en) Nucleic acid recovery method and nucleic acid recovery kit
CN100429307C (en) Nucleic acid detection method and system thereof
JPH06205676A (en) Method for extracting dna from whole blood specimen and extraction kit
WO2022116378A1 (en) Method for cleaving dna using soybean extract bowman-birk inhibitor
JP6704563B2 (en) Chaotrope and method for extracting genomic DNA using the chaotrope
JP2000146911A (en) Method for separating nucleic acid
EP0439502A1 (en) A purification process for covalently bound dna/protein complexes
CN115197997A (en) CUT & Tag method applied to plant pollen
KR20160013613A (en) Methods for isolation of nucleic acids from blood and isolation kits therefor
Hegde et al. Rapid and inexpensive method of PCR ready DNA isolation from human peripheral blood and saliva
US20090088560A1 (en) Process for Nucleic Acid Purification
JPH06289016A (en) Dna extraction reagent from living thing sample, dna extraction method using reagent, and dna extraction kit
EP1616951A1 (en) Method of isolating nucleic acid and, for nucleic acid isolation, kit and apparatus
JP2001299344A (en) Method for purifying polya+rna having high purity
CN112110992B (en) Method for cutting DNA based on flax cyclopeptide A

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21899422

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21899422

Country of ref document: EP

Kind code of ref document: A1